Johnson Financial Group Inc. Sells 1,509 Shares of UnitedHealth Group Inc (NYSE:UNH)

Johnson Financial Group Inc. lessened its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 17,237 shares of the healthcare conglomerate’s stock after selling 1,509 shares during the period. Johnson Financial Group Inc.’s holdings in UnitedHealth Group were worth $4,294,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Crewe Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Pearl River Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $35,000. Ipswich Investment Management Co. Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $40,000. OLD Second National Bank of Aurora lifted its holdings in UnitedHealth Group by 70.0% during the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock worth $42,000 after purchasing an additional 70 shares during the last quarter. Finally, Laurel Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $42,000. Institutional investors own 86.68% of the company’s stock.

In related news, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the sale, the director now owns 64,726 shares in the company, valued at $16,400,921.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $245.01, for a total value of $1,225,050.00. Following the sale, the director now owns 182,372 shares in the company, valued at approximately $44,682,963.72. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,930 shares of company stock valued at $4,587,133. 0.87% of the stock is owned by corporate insiders.

Shares of UnitedHealth Group stock traded up $4.91 on Friday, hitting $221.75. The company had a trading volume of 13,927,214 shares, compared to its average volume of 7,290,230. The company has a market cap of $212.78 billion, a PE ratio of 17.22, a price-to-earnings-growth ratio of 1.19 and a beta of 0.79. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, topping the consensus estimate of $3.60 by $0.13. The firm had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business posted $3.04 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Inc will post 14.7 EPS for the current year.

Several brokerages have weighed in on UNH. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 27th. Credit Suisse Group reissued a “buy” rating and set a $310.00 price target on shares of UnitedHealth Group in a report on Friday, February 8th. Oppenheimer boosted their price target on UnitedHealth Group from $300.00 to $305.00 and gave the stock an “outperform” rating in a report on Wednesday, January 16th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 19th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $310.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 15th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $291.56.

TRADEMARK VIOLATION WARNING: “Johnson Financial Group Inc. Sells 1,509 Shares of UnitedHealth Group Inc (NYSE:UNH)” was posted by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://www.baseballdailydigest.com/news/2019/04/21/johnson-financial-group-inc-trims-holdings-in-unitedhealth-group-inc-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Why is Cost of Capital Important?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.